Cost Savings Achieved through Introduction of Holmium Laser Enucleation of the Prostate (HOLEP) (original) (raw)

This retrospective cohort study examines the cost-effectiveness of Holmium Laser Enucleation of the Prostate (HOLEP) compared to traditional transurethral resection of the prostate (B TURP) in patients with Benign Prostatic Hyperplasia (BPH). Analyzing data from 150 male participants, the findings indicate that HOLEP provides significantly shorter lengths of hospitalization without compromising postoperative outcomes. Though initial costs of HOLEP are higher, substantial long-term cost savings are expected, particularly as the surgical technique gains familiarity. Recommendations for future research include larger patient samples and extended follow-up periods.